Serum lipids in drug addicts;Sérové lipidy u drogově závislých osob

Vnitrni Lekarstvi

Volumn 50, Issue 8, 2004, Pages 584-586

  Wilczek, H ^a   Ceska R ^a   Zlatohlavek L ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

HDL cholesterol; Heroin addiction; Prevention; Recommended values; Serum lipids

Indexed keywords

CHOLESTEROL; DIAMORPHINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; HEROIN DEPENDENCE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; REFERENCE VALUE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; FEMALE; HEROIN DEPENDENCE; HUMANS; LIPIDS; MALE; MIDDLE AGED;

EID: 4444288440     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wilczek, H., Veselý, Z., Presl, J.: Pilotní studie k dlouhodobému sledování zdravotního stavu abuzérů závislých na opiátech léčeny̌ch metadonem. Čas. Lék. čes. 141, 2002, 393-397
2. Buydens-Branchey, L., Branchey, M., Hudson, J. et al.: Low HDL-cholesterol, aggression and altered central serotonergic activity. Psychiatry Res. 6, 1993, 93-102
3. Buydens-Branchey, L., Branchey, M.: Association between low plasma levels of cholesterol and relaps in cocain addiction. Psychosom. Med. 65, 2003, 86-91
4. Christoff, N., Lortholary, O., Casassus, P. et al.: Serum lipid concentration with the reference to the immunological status in infected men. Ann. Med. Interne (Paris) 146, 1995, 490-495
5. Muga, R., J., Rey-Joly, C. et al.: Dyslipemia and HIV-1 Infection in intravenous drug addicts. Med. Clin. (Barc.) 6, 1993, 161-163
6. Češka, R.: Metabolicky̌ syndrom, HDL-cholesterol, diabetická dyslipidemie a kardiovaskulární riziko. Současná klinická praxe 1, 2002, 5-14
7. Lange, R. A., Hillis, L. D.: Cardiovascular complications of Cocaine Use. N. Engl. J. Med. 345, 2001, 351-358
8. Berg, J. E., Hostmark, A. T.: Cardiovascular risk factors in young drug addicts. Addiction Biology 1, 1996, 297-302
9. Cífková, R., Škodová, Z., Lánská, V. et al.: Longitudinální trendy celkového a HDL- cholesterolu u reprezentativního vzorku populace České republiky. Vnitř. Lék., 46, 2000, 501-505
10. Cífková, R.: Prevence ischemické choroby srdeční v dospělém věku. Kapitoly z kardiologie 2, 2000, 122-139
11. Naeem, M., Bacon, B. R., Mistry, B. et al.: Changes in serum lipoprotein profile during interferon therapy of chronic hepatitis C. Am. J. Gastroenterol. 96, 2001, 2468-2472
12. Fernandez-Miranda, C., Castellano, G., Guijarro, C. et al.: Lipoprotein changes in patients with chronic hepatitis C treatment with interferon-alpha. Am. J. Gastroenterol. 93, 1998, 1901-1904
13. Torti, C., Patroni, A., Tinelli, C. et al.: Influence of hepatitis C virus coinfection on lipid abnormalities in HIV-positive patients after highly active antiretroviral therapy. J. Acquir. Immune. Defic. Syndr. 29, 2002, 315-317
14. Blackman, B. T.: Cocaine use and acute coronary syndromes. Lancet 358, 2001, 1367
15. Del Ben, M., Maccioni, D., Scarno, A. et al.: Cocaine use and acute coronary syndromes. Lancet 358, 2001, 1369
16. Executive summary of the third report of the NCEP expert panel on detection, evaluation and treatment of high blood cholesterol in addults. JAMA 285, 2001, 2486-2497
17. Expert Group Recommends the Role of HDL-cholesterol in the Prevence and Treatment of Coronary heart disease. Am. J. Cardiol. 90, 2002, 139-143
18. Moriya, K., Shintani, Y., Fujie, H. et al.: Serum lipid profile of patients with genotype 1b hepatitis C infection in Japan. Hepatol. Res. 25, 2003, 371-376
19. De Vos, J. W., Ufkes, J. G. R., van Brussel, G. H. A. et al.: Craving despite extremely high methadone dosage. Drug and Alcohol Dependence 40, 1996, 181-184
20. Popov, P., Bečka, J., Wilczek, H.: Některé poznatky z komplexní péče o drogově závislé za 5 roků činnosti metadonového centra ve VFN Praha. Vnitř Lék., 49, 2003, 851-858
21. Češka, R.: Co nového v lipidologii. JAMA-CS 9, 2001, 728-730